The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,810.00
Bid: 1,811.00
Ask: 1,811.50
Change: 0.00 (0.00%)
Spread: 0.50 (0.028%)
Open: 1,805.00
High: 1,812.50
Low: 1,797.00
Prev. Close: 1,810.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MARKET PULSE-Gigatronics, Everyware, Clovis Oncology, Arctic Cat

Mon, 02nd Jun 2014 16:43

(For more market insights, including options activity, click on ; for the Day Ahead newsletter http://link.reuters.com/mex49s; for the Morning News Call newsletter, http://link.reuters.com/nex49s)U.S. stocks edged lower on Monday, falling from record levels asa weaker-than-expected read on manufacturing gave traders anexcuse to sell. The Dow Jones industrial average was up0.11 percent at 16,735.12 and the S&P 500 was up 0.03percent at 1,924.08.

** GOOGLE INC, $561.33, -1.81 pct

Google services are being disrupted in China ahead of thisweek's 25th anniversary of the 1989 crackdown on pro-democracydemonstrators around Beijing's Tiananmen Square, a censorshipwatchdog said on Monday.

** GIGATRONICS INC, $2.65, +119.01 pct

The company said it had received orders valued at about $6.9million from a major aerospace company for the delivery of YIG(Yttrium Iron Garnet) filters used in wireless communication.Gigatronics did not name the customer but said it "will be asupplier of filter systems for all three of the US designed 4thgeneration fighters." Gigatronics also said it was expecting anorder later this year for about $10 million associated with theproduction units.

** EVERYWARE GLOBAL INC, $1.78, +61.82 pct

The company, which sells dinnerware and kitchen gadgets,said on Saturday that its asset-backed loan lenders agreed notto exercise their rights and remedies till June 30 following adefault on certain covenants.

Everyware said it also intends to partially reopen itsMonaca, Pennsylvania facility.

** BEBE STORES INC, $3.36, -17.55 pct

The women's apparel retailer's Chief Executive SteveBirkhold has sold 140,980 shares of the company at an averageprice of $4.07, a regulatory filing late on Friday revealed. (http://link.reuters.com/beq79v)

** NPS PHARMACEUTICALS INC, $33.92, +8.96 pct

London-listed drugmaker Shire Plc has secured a $5billion credit facility for a takeover offer forNew-Jersey-based NPS Pharmaceuticals, The Times of Londonreported on Sunday. Insiders told The Times that an initialapproach to NPS by Shire has been rebuffed.

** MASTEC INC, $32.18, -10.61 pct

The infrastructure construction company said on Sunday thatit now estimates second-quarter revenue of about $1.1 billion,below its previous forecast of $1.15 billion to $1.2 billion.The company cited lower than previously expected revenue fromwireless projects and the oil and gas segment for the revision.

Stifel Nicolaus cut its price target on the stock to $45from $49 on Monday.

** PROTECTIVE LIFE CORP, $58.5, +11.85 pct

Japanese insurer Dai-ichi Life Co is in advancedtalks to buy U.S. peer Protective Life in a deal that could beworth over $5 billion, extending a drive to buy assets abroad asan antidote to a weak domestic outlook.

** CLOVIS ONCOLOGY,

The company reported positive data from an early stage studytesting its experimental lung cancer drug on Friday, but said 22percent of patients experienced high-blood sugar severe enoughto warrant treatment.

The drug - similar to AstraZeneca Plc's AZD9291 - isdesigned to target non-small cell lung cancer containing agenetic mutation.

** BROADCOM CORP, $34.85, +9.35 pct

The chipmaker said it was looking to sell or wind down itscost-intensive cellular baseband business that is hurting itsoperating income due to high research and development costs.

** ARCTIC CAT INC $33.65, -9.79 pct

The maker of all-terrain vehicles and snowmobiles said ChiefExecutive Claude Jordon has stepped down. The company namedChris Twomey as interim CEO.

** NORDION INC $12.86, +7.62 pct

U.S.-based Sterigenics International has sweetened itstakeover offer for Nordion Inc, the Canadian medicalisotope producer, to $805 million after a previous bid failed toattract enough shareholder support, Nordion said on Monday.

** ARIAD PHARMACEUTICALS INC, $6.94, +7.43 pct

The company said longer-term data from two studies of itsleukemia drug, Iclusig, showed that the drug continues to beeffective in patients who have already received treatment.

Iclusig was allowed a restricted return to the U.S. marketin December, after sales were suspended due to safety concerns.

** JUMEI INTERNATIONAL HOLDING LTD, $29.42, +6.98pct

Brokerage JG Capital initiated coverage on the Chineseonline cosmetics retailer's stock with an "overweight" rating,saying it expects Jumei to benefit from the company's strongbrand awareness, large loyal user base and online shopping'sincreasing penetration in China.

** CONN'S INC, $48.345, +3.66 pct

The electronics and home appliance retailer reported abetter-than-expected profit for the first quarter as furnitureand mattress sales jumped about 65 percent.

** AMERICAN REALTY CAPITAL HEALTHCARE TRUST INC,$10.83, +8.84 pct

** VENTAS INC, $64.49, -3.46 pct

Ventas, one of the largest U.S. healthcare real estateinvestment trusts, said it would buy American Realty CapitalHealthcare Trust in a cash-and-stock deal valued at about $2.6billion.

** PENN VIRGINIA CORP, $14.321, -5.66 pct

The oil and gas producer said it would sell its Mississippiassets to an undisclosed buyer for about $72.7 million. Theassets had net production of about 11.9 million cubic feet ofnatural gas equivalent per day during the first quarter.

** MEADWESTVACO CORP, $42.45, +4.61 pct

Activist investor Starboard Value LP reported a 5.6 percentstake in MeadWestvaco and said the packaging materials maker'sstock was "deeply undervalued".

** CENTURY ALUMINUM CO, $14.095, +3.26 pct

Analysts at BofA Merrill Lynch upgraded the company's stockto "neutral", according to StreetInsider.com.

** EXPRESS INC, $12.52, -0.71 pct

** AEROPOSTALE INC, $3.72, -4.86 pct

Nomura Equity Research cut its price targets on the apparelretailers' stocks. The brokerage cut its price target onExpress's shares to $16 from $20, and on Aeropostale's stock to$5 from $6.

** WALTER ENERGY INC, $4.62, -5.33 pct

** ARCH COAL INC, $3.5, -1.69 pct

** ALPHA NATURAL RESOURCES INC, $3.38, +0.00 pct

** PEABODY ENERGY CORP, $16.2, +0.25 pct

The United States on Monday formally announced a plan toslash carbon emissions from the power sector by 30 percentnationwide below 2005 levels by 2030, a key element of PresidentBarack Obama's plan to tackle global warming.

For a factbox, click

** THERAVANCE BIOPHARMA, $27.94, -2.48 pct

Robert W. Baird & Co analyst Brian Skorney downgraded thebiotechnology company's stock to "neutral" from "outperform",saying, "We think the stock may be particularly volatile in thenear term and see little fundamental upside without betterclarity into acceleration of Breo and Anoro sales."

Breo and Anoro are two FDA-approved treatments developed bythe company in collaboration with GlaxoSmithKline Plc for chronic obstructive pulmonary disease, a serious lungcondition.

Theravance said it would split into two publicly traded U.S.companies in April last year, separating some of its mostadvanced respiratory drugs from its other biopharmaceuticaloperations.

** ALLERGAN INC, $170.25, +1.67 pct

** VALEANT PHARMACEUTICALS INC , $131.39, +0.14 pct

Valeant Pharmaceuticals Inc on Monday prepared totake its $53.8 billion takeover bid for Allergan directly to theBotox maker's shareholders, and ally Pershing Square called fora meeting to turn over the target company's board.

For a BREAKINGVIEWS column,

** RICE ENERGY INC, $31.32, -1.29 pct

** ANTERO RESOURCES CORP, $61.98, +0.78 pct

** CHESAPEAKE ENERGY CORP, $29.21, +1.71 pct

** GULFPORT ENERGY CORP, $61.84, +0.50 pct

** RANGE RESOURCES CORP, $92.54, -0.44 pct

** STONE ENERGY CORP, $43.71, -1.53 pct

Natural gas producer Rice Energy, which went public earlierthis year, said it had successfully tested its first Utica Shalewell in Ohio.

The well, the Bigfoot 9H, had a stabilized production rateof 41.69 million cubic feet per day (mmcf/d) of gas, the companysaid. The market estimate was at about 30 mmcf/d, analysts atTudor, Pickering, Holt & Co said in a note.

The high production rate was a positive for otherexploration and production companies with exposure to the drygas window of the Utica, analysts said.

** AMTRUST FINANCIAL SERVICES INC, $41.43, -2.97pct

An article on Barron's weekly said the property and casualtyinsurer could be under-reserved due to certain accountingdisparities. (http://r.reuters.com/kaq79v)

(Compiled by Shubhankar Chakravorty in Bangalore; Editing bySriraj Kalluvila)

More News
22 Jan 2024 17:08

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies will urge a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 09:34

IN BRIEF: Oxford Nanopore appoints Keher to CFO as Cowper becomes COO

Oxford Nanopore Technologies - Oxford, England-based company specialising in nanopore DNA-sequencing - Appoints Nick Keher as chief financial officer and director, effective immediately. Keher will replace Tim Cowper as he moves into a new role as Oxford Nanopore's chief operating officer. The company says that Cowper has been performing the majority of COO duties for the past five years, and that he will lead the company's efforts to expand its international footprint. The company also says that new CFO Keher possesses "significant experience of financial leadership of complex, scientific businesses", having served in similar roles at Clinigen Group PLC, BenevolentAI SA, Royal Bank of Canada, Investec PLC and GSK PLC.

Read more
17 Jan 2024 09:38

UPDATE: GSK raises GBP978 million as cuts stake in Haleon to 4.2%

(Alliance News) - GSK PLC early Wednesday confirmed it agreed to sell 300 million shares in Haleon PLC, reducing its remaining stake in the consumer healthcare products spin-off to just 4.2%.

Read more
17 Jan 2024 08:05

GSK raises £978m through Haleon share sale

(Sharecast News) - GSK said on Wednesday that it has raised around £978m from the sale of shares in Haleon.

Read more
17 Jan 2024 07:46

LONDON BRIEFING: UK inflation surprises as unexpectedly rises to 4.0%

(Alliance News) - Stocks in London are called to open lower on Wednesday, following some hotter-than-expected consumer price data from the UK.

Read more
17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

Read more
16 Jan 2024 17:04

GSK to sell GBP1 billion worth of Haleon shares as trims stake again

(Alliance News) - GSK PLC on Tuesday said it intends to sell around GBP1.00 billion worth of shares in Haleon PLC, as it continues to reduce its shareholding in the Weybridge, Surrey-based consumer healthcare spin-off.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
16 Jan 2024 07:37

LONDON BRIEFING: UK jobless rate sticks at 4.2% but pay growth slows

(Alliance News) - Stocks in London are called to open lower on Tuesday, following data showing that the UK jobless rate was unchanged at 4.2% as pay growth slowed.

Read more
15 Jan 2024 08:42

Zantac fallout unfairly weighing on GSK, says Shore Capital

(Sharecast News) - Shore Capital has raised its target price and maintained a positive stance on biopharma giant GSK, saying that worries about the potential cost of Zantac litigation are unfairly weighing on the stock.

Read more
10 Jan 2024 09:35

LONDON BROKER RATINGS: BofA cuts Ashtead; UBS likes 3i Group

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
10 Jan 2024 08:25

GSK says Nucala gets green light in China for asthma treatment

(Alliance News) - GSK PLC on Wednesday said Nucala has been approved in China for the treatment of severe asthma.

Read more
10 Jan 2024 07:22

GSK's Nucala gets fresh approval in China

(Sharecast News) - GSK announced on Wednesday that the China National Medical Products Administration (NMPA) has granted approval for 'Nucala', or mepolizumab, as an add-on maintenance treatment for severe eosinophilic asthma in adults and adolescents aged 12 years and older.

Read more
9 Jan 2024 16:22

London close: Stocks finish red after choppy session

(Sharecast News) - London stocks had turned back into the red by the close on Tuesday, with recruitment firms and asset managers pacing the declines after some disappointing corporate updates.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.